Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schuchat

Showing results (41-50 of 209) with videos related to

Pageof 21
Sort By:
Microbiology Spectrum|May 27, 2016
Measles in the United States since the Millennium: Perils and Progress in the Postelimination EraAnne Schuchat, Amy Parker Fiebelkorn, William Bellini
Infectious Diseases in Obstetrics and Gynecology|January 1, 1996
Ethical issues associated with routine screening and prophylaxis for group B streptococcus in pregnancyM K Yancey, A Schuchat, P Duff
JAMA|November 29, 2017
Prescription Drug Monitoring Programs and Opioid Death Rates-ReplyAnne Schuchat, Gery P Guy, Deborah Dowell
The New England Journal of Medicine|April 8, 2003
A human papillomavirus type 16 vaccineStephanie J Schrag, Anne Schuchat, Jay Schulkin
JAMA|July 9, 2017
New Data on Opioid Use and Prescribing in the United StatesAnne Schuchat, Debra Houry, Gery P Guy
Clinical Microbiology Reviews|April 1, 1991
Epidemiology of human listeriosisA Schuchat, B Swaminathan, C V Broome
The Pediatric Infectious Disease Journal|March 27, 1999
Prevention of perinatal group B streptococcal infectionsJ Y Morita, K L O'Brien, A Schuchat
The Lancet. Infectious Diseases|April 8, 2003
Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsisMatthew R Moore, Stephanie J Schrag, Anne Schuchat
MMWR Supplements|October 7, 2011
Vaccine-preventable diseases, immunizations, and MMWR--1961-2011Alan R Hinman, Walter A Orenstein, Anne Schuchat, et al.
Infection Control and Hospital Epidemiology|August 5, 2000
Neonatal group B streptococcal disease: how infection control teams can contribute to prevention effortsS J Schrag, C G Whitney, A Schuchat
Pageof 21

Showing results (41-50 of 209) with videos related to

Sort By:
Pageof 21
Microbiology Spectrum|May 27, 2016
Measles in the United States since the Millennium: Perils and Progress in the Postelimination EraAnne Schuchat, Amy Parker Fiebelkorn, William Bellini
Infectious Diseases in Obstetrics and Gynecology|January 1, 1996
Ethical issues associated with routine screening and prophylaxis for group B streptococcus in pregnancyM K Yancey, A Schuchat, P Duff
JAMA|November 29, 2017
Prescription Drug Monitoring Programs and Opioid Death Rates-ReplyAnne Schuchat, Gery P Guy, Deborah Dowell
The New England Journal of Medicine|April 8, 2003
A human papillomavirus type 16 vaccineStephanie J Schrag, Anne Schuchat, Jay Schulkin
JAMA|July 9, 2017
New Data on Opioid Use and Prescribing in the United StatesAnne Schuchat, Debra Houry, Gery P Guy
Clinical Microbiology Reviews|April 1, 1991
Epidemiology of human listeriosisA Schuchat, B Swaminathan, C V Broome
The Pediatric Infectious Disease Journal|March 27, 1999
Prevention of perinatal group B streptococcal infectionsJ Y Morita, K L O'Brien, A Schuchat
The Lancet. Infectious Diseases|April 8, 2003
Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsisMatthew R Moore, Stephanie J Schrag, Anne Schuchat
MMWR Supplements|October 7, 2011
Vaccine-preventable diseases, immunizations, and MMWR--1961-2011Alan R Hinman, Walter A Orenstein, Anne Schuchat, et al.
Infection Control and Hospital Epidemiology|August 5, 2000
Neonatal group B streptococcal disease: how infection control teams can contribute to prevention effortsS J Schrag, C G Whitney, A Schuchat
Pageof 21